Genomics England: Rich Scott, Chris Wigley
Rich Scott has been appointed as interim CEO of Genomics England, effective Oct. 31. He succeeds Chris Wigley, who assumed the CEO post in 2019 and said this spring that he would resign to take on a role in the private sector. Scott, who is currently acting CEO, joined Genomics England in 2015 and has been its chief medical officer since 2021. He is also a consultant and honorary associate professor in clinical genetics at Great Ormond Street Hospital for Children and the UCL Institute of Child Health.